DK0594570T3 - Colestyraminholdige mikrotabletter som lipidsænkende middel - Google Patents

Colestyraminholdige mikrotabletter som lipidsænkende middel

Info

Publication number
DK0594570T3
DK0594570T3 DK90913811.7T DK90913811T DK0594570T3 DK 0594570 T3 DK0594570 T3 DK 0594570T3 DK 90913811 T DK90913811 T DK 90913811T DK 0594570 T3 DK0594570 T3 DK 0594570T3
Authority
DK
Denmark
Prior art keywords
colestyramine
lipid
lowering agent
containing micro
micro tablets
Prior art date
Application number
DK90913811.7T
Other languages
English (en)
Inventor
Thomas Moest
Erwin Spiegel
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19893930206 external-priority patent/DE3930206A1/de
Priority claimed from DE3930168A external-priority patent/DE3930168A1/de
Application filed by Knoll Ag filed Critical Knoll Ag
Application granted granted Critical
Publication of DK0594570T3 publication Critical patent/DK0594570T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK90913811.7T 1989-09-09 1990-09-07 Colestyraminholdige mikrotabletter som lipidsænkende middel DK0594570T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19893930206 DE3930206A1 (de) 1989-09-09 1989-09-09 Pharmazeutische erzeugnisse
DE3930168A DE3930168A1 (de) 1989-09-09 1989-09-09 Verbesserte verabreichungsform fuer colestyramin

Publications (1)

Publication Number Publication Date
DK0594570T3 true DK0594570T3 (da) 1995-09-11

Family

ID=25884990

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90913811.7T DK0594570T3 (da) 1989-09-09 1990-09-07 Colestyraminholdige mikrotabletter som lipidsænkende middel

Country Status (10)

Country Link
EP (1) EP0594570B1 (da)
JP (1) JPH05500213A (da)
KR (1) KR920703071A (da)
AT (1) ATE125448T1 (da)
AU (1) AU638493B2 (da)
CA (1) CA2065151A1 (da)
DE (1) DE59009451D1 (da)
DK (1) DK0594570T3 (da)
IL (1) IL95574A (da)
WO (1) WO1991003249A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE030062T2 (en) 2010-11-08 2017-04-28 Albireo Ab IBAT inhibitors for the treatment of liver diseases
WO2015199147A1 (ja) 2014-06-25 2015-12-30 味の素株式会社 固形製剤及びその着色防止又は着色低減方法
EP3012252A1 (en) 2014-10-24 2016-04-27 Ferring BV Crystal modifications of elobixibat
CA3011565C (en) * 2016-02-09 2024-01-02 Albireo Ab Oral cholestyramine formulation and use thereof
EP3413875B1 (en) * 2016-02-09 2020-01-29 Albireo AB Cholestyramine pellets and methods for preparation thereof
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
JP6954927B2 (ja) * 2016-02-09 2021-10-27 アルビレオ・アクチボラグ 経口コレスチラミン製剤及びその使用
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
EP3664781A1 (en) 2017-08-09 2020-06-17 Albireo AB Cholestyramine granules, oral cholestyramine formulations and use thereof
CA3071182A1 (en) * 2017-08-09 2019-02-14 Albireo Ab Cholestyramine pellets, oral cholestyramine formulations and use thereof
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
TW202015699A (zh) 2018-06-05 2020-05-01 瑞典商艾爾比瑞歐公司 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽汁酸調節劑之用途
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
BR112020024479A2 (pt) 2018-06-20 2021-03-02 Albireo Ab hidrato cristalino, modificações cristalinas de odevixibat, solvato misto de odevixibat, uso de modificação cristalina de odevixibat, processo para a preparação de modificação cristalina de odevixibat, e, composição farmacêutica
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
DK4069360T3 (da) 2019-12-04 2024-02-26 Albireo Ab Benzothia(di)azepinforbindelser og anvendelse deraf som galdesyremodulatorer
EP4069361B1 (en) 2019-12-04 2024-01-03 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
CA3158184A1 (en) 2019-12-04 2021-08-10 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
ES2972045T3 (es) 2019-12-04 2024-06-10 Albireo Ab Compuestos de benzotia(di)azepina y su uso como moduladores del ácido biliar
CN116157389A (zh) 2020-08-03 2023-05-23 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
EP4243831A1 (en) 2020-11-12 2023-09-20 Albireo AB Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
BR112023010799A2 (pt) 2020-12-04 2023-10-03 Albireo Ab Compostos de benzotia(di)azepina e seus usos como moduladores de ácidos biliares

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1348642A (en) * 1970-10-15 1974-03-20 Howard A N Hypocholesterolaemic compositions
GB1566609A (en) 1977-03-10 1980-05-08 Reckitt & Colmann Prod Ltd Pharmaceutical compositions containing cholestyramine and alginic acid
DE3572440D1 (en) 1984-06-19 1989-09-28 Basf Ag Gastro-resistant cylindrical pancreatine-microtablets
ZA876640B (en) 1986-09-26 1988-03-08 Warner-Lambert Company Treated lipid regulator
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
CA1313135C (en) * 1987-02-09 1993-01-26 The Dow Chemical Company Cholestyramine composition and process for its preparation
EP0323666B1 (en) * 1987-12-29 1992-03-25 The Procter & Gamble Company Mixed compositions for treating hypercholesterolemia
DE3808191C2 (de) 1988-03-11 1998-08-06 Astra Chem Gmbh Colestyramin enthaltende pharmazeutische Zusammensetzung
US4931280A (en) 1988-06-13 1990-06-05 Basf K & F Corporation Edible, baked compositions containing cholestyramine

Also Published As

Publication number Publication date
WO1991003249A1 (de) 1991-03-21
AU638493B2 (en) 1993-07-01
ATE125448T1 (de) 1995-08-15
EP0594570B1 (de) 1995-07-26
AU6405790A (en) 1991-04-08
DE59009451D1 (de) 1995-08-31
IL95574A (en) 1994-11-11
EP0594570A1 (de) 1994-05-04
KR920703071A (ko) 1992-12-17
JPH05500213A (ja) 1993-01-21
CA2065151A1 (en) 1991-03-10
IL95574A0 (en) 1991-06-30

Similar Documents

Publication Publication Date Title
DK0594570T3 (da) Colestyraminholdige mikrotabletter som lipidsænkende middel
FI924553A (fi) Tiofensulfonamider anvaendbara som kolanhydrasinhibitorer
NO900227D0 (no) Ekstruderbar elastisk gel for anvendelse som baerer for terapeutisk middel.
FI921606A0 (fi) Mikroperoxidas innehaollande hemopeptid som aktiv komponent.
NL960002I1 (nl) Nieuwe taxolderivaten,werkwijzen ter bereiding daarvan en farmaceutische preparaten,die deze bevatten.
FI922454A (fi) Peptider och antikroppar som inhiberar integrinligandbindning.
FI921279A0 (fi) Amino-b-lyasenzyminhibitorer som deodoranter.
FI905933A0 (fi) Multilager film som haeftar vid koett.
FI900762A0 (fi) Tris-hydroximetylalkanestrar som fettimitationer med laog kalorihalt.
FI900763A0 (fi) Tris-hydroximetyl-laegre alkanestrar som fettsurrogat.
NO963497D0 (no) Fibrin-spesifikt antistoff for anvendelse som et antitrombotisk middel
IT1233330B (it) Lampada da tavolo.
FI895483A (fi) Som slaglod anvaendbara kopparblandningar.
FI884545A0 (fi) Farmaceutisk komposition, som innehaoller avsvaellande piperidinoalkanolfoereningar.
NO901672D0 (no) Blanding til bruk som overflateaktivt middel i vaskemidler
FI945609A0 (fi) Makromonomeereja sisältävät vesipitoiset lateksit
FI900940A0 (fi) Tryckt kretsskiva som foerhindrar elektromagnetisk interferens.
FI905238A0 (fi) Foerbraenningsmotor foer fartyg som transporterar foerbraenningsgas.
NO901169L (no) Azol-1-alkanamider som anti-arrytmiske midler og fremstilling derav.
FI883453A (fi) Bicyklooktanderivat anvaendbara som pesticider och foerfarande foer deras framstaellning.
FI914146A0 (fi) Foerfarande foer behandling av metaller som avgjutit medelst sprutning.
FI903885A0 (fi) Ny oral farmaceutisk doseringsform som foerbaettrar biotillgaengligheten.
FI903111A0 (fi) Bis (benzylpyrrolidin) derivat som dopaminantagonister.
NO901200L (no) Azol-1-alkanamider som anti-arrytmiske midler og fremstilling derav.
FR2654835B1 (fr) Microcolonnes de chromatographie.